These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Development of a Mouse Model of Shiga Toxin 2 (Stx2) Intoxication for Testing Therapeutic Agents Against Hemolytic Uremic Syndrome (HUS). Mejias MP; Fernandez-Brando RJ; Ramos MV; Abrey-Recalde MJ; Zotta E; Meiss R; Palermo MS Curr Pharm Des; 2016; 22(34):5294-5299. PubMed ID: 27356777 [TBL] [Abstract][Full Text] [Related]
24. Immunization with a chimera consisting of the B subunit of Shiga toxin type 2 and brucella lumazine synthase confers total protection against Shiga toxins in mice. Mejias MP; Ghersi G; Craig PO; Panek CA; Bentancor LV; Baschkier A; Goldbaum FA; Zylberman V; Palermo MS J Immunol; 2013 Sep; 191(5):2403-11. PubMed ID: 23918978 [TBL] [Abstract][Full Text] [Related]
25. Mouse model of hemolytic-uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Sauter KA; Melton-Celsa AR; Larkin K; Troxell ML; O'Brien AD; Magun BE Infect Immun; 2008 Oct; 76(10):4469-78. PubMed ID: 18694970 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of I-Ad-, but not Db-restricted peptide-induced thymic apoptosis by glucocorticoid receptor antagonist RU486 in T cell receptor transgenic mice. Xue Y; Murdjeva M; Okret S; McConkey D; Kiuossis D; Jondal M Eur J Immunol; 1996 Feb; 26(2):428-34. PubMed ID: 8617314 [TBL] [Abstract][Full Text] [Related]
27. Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters. King AJ; Sundaram S; Cendoroglo M; Acheson DW; Keusch GT J Infect Dis; 1999 Feb; 179(2):503-7. PubMed ID: 9878039 [TBL] [Abstract][Full Text] [Related]
28. Activation of equine neutrophils by phorbol myristate acetate or N-formyl-methionyl-leucyl-phenylalanine induces a different response in reactive oxygen species production and release of active myeloperoxidase. Franck T; Kohnen S; de la Rebière G; Deby-Dupont G; Deby C; Niesten A; Serteyn D Vet Immunol Immunopathol; 2009 Aug; 130(3-4):243-50. PubMed ID: 19328559 [TBL] [Abstract][Full Text] [Related]
33. Significance of endogenous glucocorticoid sensitivity for airway eosinophilia in a murine model of allergy. Georén S; Ahnblad P; Stjärne P; Wikström AC; Stierna P Acta Otolaryngol; 2005 Apr; 125(4):378-85. PubMed ID: 15823808 [TBL] [Abstract][Full Text] [Related]
34. Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model. Song L; Xiao Y; Li X; Huang Y; Meng G; Ren Z Front Immunol; 2020; 11():619096. PubMed ID: 33552083 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Flagler MJ; Strasser JE; Chalk CL; Weiss AA Infect Immun; 2007 Feb; 75(2):760-5. PubMed ID: 17101648 [TBL] [Abstract][Full Text] [Related]
36. Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. Ge S; Hertel B; Emden SH; Beneke J; Menne J; Haller H; von Vietinghoff S Nephrol Dial Transplant; 2012 Jul; 27(7):2768-75. PubMed ID: 22234918 [TBL] [Abstract][Full Text] [Related]
37. Reactivity of purified complement component 3b with bovine neutrophils and modulation of complement receptor 1. Di Carlo AL; Paape MJ; Miller RH Am J Vet Res; 1996 Feb; 57(2):151-6. PubMed ID: 8633799 [TBL] [Abstract][Full Text] [Related]
38. Genetic variations in Shiga toxin-producing abilities of bovine and human Escherichia coli O157:H7. Taylor EV; Shi X; Alam MJ; Peterson G; Narayanan SK; Renter DG; Nagaraja TG Zoonoses Public Health; 2011 May; 58(3):185-91. PubMed ID: 20819202 [TBL] [Abstract][Full Text] [Related]
39. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Wen SX; Teel LD; Judge NA; O'Brien AD Vaccine; 2006 Feb; 24(8):1142-8. PubMed ID: 16198455 [TBL] [Abstract][Full Text] [Related]
40. Protective role of nitric oxide in mice with Shiga toxin-induced hemolytic uremic syndrome. Dran GI; Fernández GC; Rubel CJ; Bermejo E; Gomez S; Meiss R; Isturiz MA; Palermo MS Kidney Int; 2002 Oct; 62(4):1338-48. PubMed ID: 12234304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]